The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this study was to determine the effect of complex decongestive physiotherapy in women with unilateral breast cancer-related lymphedema on sensory parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2019
CompletedFirst Submitted
Initial submission to the registry
March 2, 2020
CompletedFirst Posted
Study publicly available on registry
March 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 5, 2020
March 1, 2020
1.3 years
March 2, 2020
March 3, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Touching sensation
Assessment of touching sensation at 10 cm distal to the elbow on the volar surface in affected and unaffected arms at least 12 months after the breast cancer treatment, with Semmes-Weinstein Monofilaments in women with breast cancer related lymphedema.
Change from Baseline touching sensation at 3 weeks
Two-point discrimination
Assessment of two-point discrimination at 10 cm distal to the elbow on the volar surface in affected and unaffected arms at least 12 months after the breast cancer treatment, with an esthesiometer in women with breast cancer related lymphedema.
Change from baseline two-point discrimination at 3 weeks
Pressure pain threshold
Assessment of pressure pain threshold at 10 cm distal to the elbow on the volar surface in affected and unaffected arms at least 12 months after the breast cancer treatment, with an algometer in women with breast cancer related lymphedema.
Change from baseline pressure pain threshold at 3 weeks
Secondary Outcomes (5)
Vibration sensation
Change from baseline vibration sensation at 3 weeks
Ultrasonographic Imaging
Change from baseline ultrasonographic imaging at 3 weeks.
Environmental measurement
Change from baseline environmental measurement at 3 weeks.
Hot / Cold Sensory Test
Change from baseline Hot/Cold sensory Test at 3 weeks
Lymphedema Life Impact Scale
Change from baseline Lymphedema Life Impact Scale at 3 weeks.
Study Arms (2)
Affected arm in lymphedema patients
EXPERIMENTALComplex decongestive physiotherapy treatment will be applied to the arm (affected arm) that develops lymphedema after unilateral breast cancer treatment.
Unaffected arm in lymphedema patients
NO INTERVENTIONAfter unilateral breast cancer treatments, the non-lymphedema side in the upper extremities, is the unaffected arm. No treatments will be applied to the unaffected side.
Interventions
Complete decongestive therapy (CDT), also called complex decongestive therapy, is an intensive program that combines many of the different treatment approaches, including bandaging, compression garments, manual lymphatic drainage, exercise, and self care.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of lymphedema disease
- Ages between 18-80 years old,
- cm difference between the affected and unaffected arms in women with breast cancer related lymphedema,
- At least 12 months after breast cancer treatments end and
- Who are agreed to participate in the study.
You may not qualify if:
- Women with active infection,
- deep vein thrombosis/thrombophlebitis,
- cardiac edema,
- peripheral artery disease,
- kidney, lung disease,
- primary lymphedema,
- peripheral upper limb nerve injury,
- any surgery other than breast cancer surgeries,
- existing shoulder, elbow, wrist, hand pathologies,
- cooperation problems,
- neurological disease,
- mental illness, diabetes mellitus,
- smoking and patients with open wounds on the upper limb.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Samanpazari, 06100, Turkey (Türkiye)
Related Publications (18)
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
PMID: 25220842BACKGROUNDRibeiro Pereira ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast. 2017 Dec;36:67-73. doi: 10.1016/j.breast.2017.09.006. Epub 2017 Oct 6.
PMID: 28992556BACKGROUNDRijke AM, Croft BY, Johnson RA, de Jongste AB, Camps JA. Lymphoscintigraphy and lymphedema of the lower extremities. J Nucl Med. 1990 Jun;31(6):990-8.
PMID: 2348245BACKGROUNDGoyal A, Newcombe RG, Chhabra A, Mansel RE. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol. 2008 Jan;15(1):262-7. doi: 10.1245/s10434-007-9593-3. Epub 2007 Sep 19.
PMID: 17879117BACKGROUNDWu SG, Huang SJ, Zhou J, Sun JY, Guo H, Li FY, Lin Q, Lin HX, He ZY. Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy. Radiat Oncol. 2014 Dec 12;9:292. doi: 10.1186/s13014-014-0292-5.
PMID: 25499205BACKGROUNDWarmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer. 1998 Oct 1;83(7):1362-8. doi: 10.1002/(sici)1097-0142(19981001)83:73.0.co;2-2.
PMID: 9762937BACKGROUNDAndersen KG, Duriaud HM, Kehlet H, Aasvang EK. The Relationship Between Sensory Loss and Persistent Pain 1 Year After Breast Cancer Surgery. J Pain. 2017 Sep;18(9):1129-1138. doi: 10.1016/j.jpain.2017.05.002. Epub 2017 May 11.
PMID: 28502878BACKGROUNDSay CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet. 1974 Mar;138(3):370-6. No abstract available.
PMID: 4811322BACKGROUNDGanel A, Engel J, Sela M, Brooks M. Nerve entrapments associated with postmastectomy lymphedema. Cancer. 1979 Dec;44(6):2254-9. doi: 10.1002/1097-0142(197912)44:63.0.co;2-9.
PMID: 509395BACKGROUNDFoldi M, Foldi E. [Therapy of lymphedema]. Med Welt. 1980 May 23;31(21):801-6. No abstract available. German.
PMID: 6993841BACKGROUNDLim CY, Seo HG, Kim K, Chung SG, Seo KS. Measurement of lymphedema using ultrasonography with the compression method. Lymphology. 2011 Jun;44(2):72-81.
PMID: 21949976BACKGROUNDVoerman VF, van Egmond J, Crul BJ. Normal values for sensory thresholds in the cervical dermatomes: a critical note on the use of Semmes-Weinstein monofilaments. Am J Phys Med Rehabil. 1999 Jan-Feb;78(1):24-9. doi: 10.1097/00002060-199901000-00007.
PMID: 9923425BACKGROUNDMOBERG E. Objective methods for determining the functional value of sensibility in the hand. J Bone Joint Surg Br. 1958 Aug;40-B(3):454-76. doi: 10.1302/0301-620X.40B3.454. No abstract available.
PMID: 13575459BACKGROUNDDellon AL. The moving two-point discrimination test: clinical evaluation of the quickly adapting fiber/receptor system. J Hand Surg Am. 1978 Sep;3(5):474-81. doi: 10.1016/s0363-5023(78)80143-9.
PMID: 568154BACKGROUNDGranges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum. 1993 May;36(5):642-6. doi: 10.1002/art.1780360510.
PMID: 8489541BACKGROUNDWeiss J, Daniel T. VALIDATION OF THE LYMPHEDEMA LIFE IMPACT SCALE (LLIS): A CONDITION-SPECIFIC MEASUREMENT TOOL FOR PERSONS WITH LYMPHEDEMA. Lymphology. 2015 Sep;48(3):128-38.
PMID: 26939160BACKGROUNDOrhan C, Uzelpasaci E, Baran E, Nakip G, Ozgul S, Aksoy S, Akbayrak T. The Reliability and Validity of the Turkish Version of the Lymphedema Life Impact Scale in Patients With Breast Cancer-Related Lymphedema. Cancer Nurs. 2020 Sep/Oct;43(5):375-383. doi: 10.1097/NCC.0000000000000709.
PMID: 30921030BACKGROUNDBaran E, Ozcakar L, Ozgul S, Aksoy S, Akbayrak T. Upper limb sensory evaluations and ultrasonographic skin measurements in breast cancer-related lymphedema receiving complex decongestive physiotherapy. Support Care Cancer. 2021 Nov;29(11):6545-6553. doi: 10.1007/s00520-021-06235-4. Epub 2021 Apr 29.
PMID: 33913006DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Türkan Akbayrak, Prof
Hacettepe University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant, Physical Therapist, Master of Science
Study Record Dates
First Submitted
March 2, 2020
First Posted
March 5, 2020
Study Start
November 28, 2019
Primary Completion
March 1, 2021
Study Completion
December 1, 2021
Last Updated
March 5, 2020
Record last verified: 2020-03